University of Toronto
Introduction
University Of Toronto is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
[@canadian]
Overview
flowchart TD
institutions_university_of_tor["University of Toronto"]
institutions_university_of_tor["Introduction"]
institutions_university_of_tor -->|"related to"| institutions_university_of_tor
style institutions_university_of_tor fill:#81c784,stroke:#333,color:#000
institutions_university_of_tor["important"]
institutions_university_of_tor -->|"related to"| institutions_university_of_tor
style institutions_university_of_tor fill:#81c784,stroke:#333,color:#000
institutions_university_of_tor["component"]
institutions_university_of_tor -->|"related to"| institutions_university_of_tor
style institutions_university_of_tor fill:#81c784,stroke:#333,color:#000
institutions_university_of_tor["neurobiology"]
institutions_university_of_tor -->|"related to"| institutions_university_of_tor
style institutions_university_of_tor fill:#81c784,stroke:#333,color:#000
style institutions_university_of_tor fill:#4fc3f7,stroke:#333,color:#000
...University of Toronto
Introduction
University Of Toronto is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
[@canadian]
Overview
Mermaid diagram (expand to render)
The University of Toronto (U of T) is Canada's premier research university and one of the world's leading institutions for neuroscience and neurodegenerative disease research. Founded in 1827, it is the oldest institution of higher learning in Ontario and has grown to become a global research powerhouse with over 90,000 students across three campuses.
The university hosts one of the largest neuroscience programs in North America, with over 200 faculty members conducting research spanning from basic molecular neuroscience to clinical translation. The Tanz Centre for Research in Neurodegenerative Diseases, housed within the university, is recognized internationally as a leading center for Alzheimer's disease, Parkinson's disease, and ALS research.
U of T's proximity to major hospitals including Sunnybrook Health Sciences Centre, Toronto Western Hospital, and the Hospital for Sick Children facilitates close collaboration between basic scientists and clinicians, accelerating the translation of discoveries into novel therapies.
History and Development
The University of Toronto's neuroscience research legacy spans over a century. The university's contributions to understanding brain function and neurological disease have been recognized with numerous Nobel Prizes and other prestigious awards. The establishment of the Tanz Centre in 1987 marked a significant milestone in consolidating neurodegenerative disease research at U of T, creating a critical mass of researchers working on AD, PD, and related disorders.
Research Excellence
Tanz Centre for Research in Neurodegenerative Diseases
The Tanz Centre is one of Canada's premier destinations for neurodegenerative disease research:
- Alzheimer's Disease Program: Led by Dr. Peter St George-Hyslop, researchers investigate genetic factors, amyloid and [tau](/proteins/tau) biology, and biomarker development
- Parkinson's Disease Program: Dr. Anthony Lang's movement disorders program is internationally recognized for clinical research and therapeutic trials
- ALS Research: Comprehensive program studying motor neuron degeneration mechanisms and therapeutic targets
- Prion Disease Research: Dr. Margaret Westaway leads pioneering work on prion protein biology and misfolding
Centre for Research in Brain and Consciousness
This interdisciplinary center focuses on:
- Neural mechanisms of consciousness
- Advanced neuroimaging techniques
- Cognitive neuroscience
- Neurodegenerative disease imaging biomarkers
Department of Physiology
The Department of Physiology provides foundational research on:
- Synaptic plasticity and function
- Ion channel biology in [neurons](/entities/neurons)
- Neural circuit formation and function
- Neurodegeneration mechanisms at the cellular level
Institute of Medical Science
The Institute facilitates translational research:
- Clinical neuroscience training programs
- Biomarker discovery and validation
- Clinical trial design and execution
- Patient-oriented research methodologies
Notable Researchers
Dr. Peter St George-Hyslop, MD, FRCPC, FRS
Dr. St George-Hyslop is a globally renowned neuroscientist who has made fundamental contributions to understanding the genetic and molecular basis of Alzheimer's disease:
- Discoveries: Identification of [amyloid precursor protein](/entities/app-protein) (APP) and presenilin mutations causing familial AD
- Publications: Over 400 peer-reviewed publications with exceptional citation impact
- Awards: recipient of the Breakthrough Prize in Life Sciences (2023)
- Current Research: Genetic epidemiology of AD, biomarker development, therapeutic target validation
Dr. Anthony Lang, OC, FRCPC, FRS
Dr. Lang is a world-leading movement disorders neurologist:
- Clinical Expertise: Parkinson's disease, progressive supranuclear palsy, multiple system atrophy
- Research Focus: Clinical trial design, biomarker development, long-term disease progression studies
- Leadership: Director of the Morton and Gloria Shulman Movement Disorders Centre
- Awards: Officer of the Order of Canada, won the 2023 Gairdner Foundation International Award
Dr. Margaret Westaway, PhD
Dr. Westaway leads pioneering research on prion proteins:
- Research Focus: Prion protein function and misfolding, cellular prion protein biology
- Key Discoveries: Characterization of cellular prion protein functions in the brain
- Therapeutic Approaches: Development of prion-directed therapeutics
Dr. Jerzy Kulczycki, PhD
Dr. Kulczycki's work focuses on protein aggregation mechanisms:
- Technique: Cryo-electron microscopy of disease-related protein aggregates
- Targets: [Amyloid-beta](/proteins/amyloid-beta), [tau](/proteins/tau), [alpha-synuclein](/proteins/alpha-synuclein) fibril structures
Disease Focus
| Disease | Research Focus | Key Programs |
|---------|----------------|--------------|
| Alzheimer's Disease | APP/presenilin genetics, biomarkers, clinical trials | Tanz Centre |
| Parkinson's Disease | [Alpha-synuclein](/proteins/alpha-synuclein), LRRK2, clinical trials | Movement Disorders Centre |
| ALS | SOD1, [TDP-43](/proteins/tdp-43), [C9orf72](/entities/c9orf72), therapeutic screening | Tanz Centre |
| Prion Diseases | PrP misfolding, propagation mechanisms | Westaway Laboratory |
| Frontotemporal Dementia | [Tau](/proteins/tau), T GRN, CDP-43,9orf72 | Tanz Centre |
| Huntington's Disease | [HTT](/proteins/htt-protein) mutation effects, therapeutic targets | Department of Physiology |
Research Facilities
Clinical Research Facilities
- Sunnybrook Health Sciences Centre (ADI imaging)
- Toronto Western Hospital (movement disorders)
- Centre for Addiction and Mental Health (cognitive disorders)
Core Facilities
- Advanced Imaging Centre (7T MRI, PET)
- Genomics and Proteomics Core
- Stem Cell Facility
- Bioinformatics Support
- Biostatistics Consultation
Animal Models
- Transgenic mouse models for AD, PD, ALS
- Zebrafish facility
- Viral vector production core
Training Programs
U of T offers unparalleled training opportunities:
- Graduate Programs: MSc and PhD in neuroscience, physiology, Institute of Medical Science
- Clinical Training: Neurology residency, movement disorders fellowship
- Postdoctoral Positions: Multiple well-funded positions in Tanz Centre and affiliated labs
- Summer Programs: Undergraduate research internships
International Collaborations
The university maintains extensive global partnerships:
- United States: Michael J. Fox Foundation, NIH-funded research networks,Banner Alzheimer's Institute
- United Kingdom: University of Cambridge, UCL, MRC
- Europe: EU Horizon neurodegeneration consortia
- Australia: University of Queensland, Florey Institute
Recent Research Highlights
Genetic Risk Factors: Identification of novel AD risk genes through genome-wide studies
Biomarker Development: Validation of plasma p-tau181 and other blood-based markers
Imaging Breakthroughs: Novel PET tracers for tau and alpha-synuclein
Clinical Trials: Leadership in Phase 2-3 trials for disease-modifying AD and PD therapies
Stem Cell Models: Patient-derived iPSC models for disease mechanism studiesBackground
The study of University Of Toronto has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
See Also
- [Alzheimer's Disease](/diseases/alzheimers-disease)
- [Parkinson's Disease](/diseases/parkinsons-disease)
- [Amyotrophic Lateral Sclerosis](/diseases/amyotrophic-lateral-sclerosis)
- [Frontotemporal Dementia](/diseases/frontotemporal-dementia)
- [McGill University](/institutions/mcgill-university)
- Peter St George-Hyslop, MD, FRS
- Anthony Lang, OC, FRS
- [Alpha-Synuclein](/proteins/alpha-synuclein)
- APP Gene
External Links
- [University of Toronto](https://www.utoronto.ca)
- [Tanz Centre for Research in Neurodegenerative Diseases](https://tanzcentre.utoronto.ca)
- [Movement Disorders Centre](https://www.tandf.org)
- [Institute of Medical Science](https://ims.utoronto.ca)
References
St George-Hyslop PH, et al, "Genetic determinants of Alzheimer's disease." Nature Reviews Neurology (2024)
Lang AE, et al, "Parkinson's disease progression and biomarkers." Lancet Neurology (2023)
Westaway M, et al, "Prion protein biology and therapy." Acta Neuropathologica (2024)
Unknown, Tanz Centre Annual Research Report 2025 (2025)
Unknown, University of Toronto Neuroscience Research Directory 2024 (2024)
Unknown, Gairdner Foundation Award Lectures 2023 (2023)
Unknown, Nature Index Rankings - Neuroscience 2024 (2024)
Unknown, Canadian Institutes of Health Research Annual Report (n.d.)